financetom
Business
financetom
/
Business
/
RBC's profit rises on HSBC Canada purchase, capital markets strength
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
RBC's profit rises on HSBC Canada purchase, capital markets strength
Aug 29, 2024 9:15 AM

(Reuters) -Royal Bank of Canada reported a rise in third-quarter profit on Wednesday, as the country's largest lender benefited from the acquisition of HSBC Canada and robust performance in its capital markets business.

The inclusion of HSBC Canada's results boosted net income by C$239 million, RBC said.

Dealmaking activity is on a resurgence as expectations of a soft landing have given corporate executives the confidence to push ahead with acquisitions and sell stocks and bonds to raise capital.

RBC's capital markets business recorded a 23% jump in net income to C$1.17 billion ($869.2 million).

The bank took on billions of dollars in loans after it completed the purchase of HSBC Canada in March, the largest acquisition in its history.

The bank's adjusted net income rose to C$4.73 billion, or C$3.26 per share, in the three months ended July 31, from C$4.01 billion, or C$2.83 per share, a year earlier.

($1 = 1.3457 Canadian dollars)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Medirom Healthcare Shares Rise After Investment, Partnership With Elematec
Medirom Healthcare Shares Rise After Investment, Partnership With Elematec
Oct 17, 2024
01:44 PM EDT, 10/15/2024 (MT Newswires) -- Medirom Healthcare Technologies' ( MRM ) shares jumped 27% in recent trading Tuesday after the company said Elematec, a Toyota Tsusho group member, agreed to make an investment in its unit Medirom Mother Labs. Elematec is participating in Medirom Mother Labs' series A round with pre-money valuation at 9 billion yen ($60 million),...
Rani Therapeutics Shares Fall After $10 Million Registered Direct Securities Offering Priced
Rani Therapeutics Shares Fall After $10 Million Registered Direct Securities Offering Priced
Oct 17, 2024
01:40 PM EDT, 10/15/2024 (MT Newswires) -- Rani Therapeutics Holdings ( RANI ) shares fell 23% in recent Tuesday trading after the company priced a registered direct offering of securities for gross proceeds of about $10 million. The company agreed to sell 3 million shares of class A common stock, prefunded warrants for 333,333 shares and series C common warrants...
What's Going On With XPeng Stock Today?
What's Going On With XPeng Stock Today?
Oct 17, 2024
XPeng Inc. ( XPEV ) shares are trading lower on Tuesday. Shares of U.S.-listed Chinese stocks are trading lower after China’s September exports missed estimates. Concerns over the effectiveness of China’s latest stimulus measures have also rattled investors. According to Benzinga Pro, XPEV stock has lost over 25% in the past year. Investors can gain exposure to the stock via Invesco WilderHill Clean...
Sanofi Might Face Political Hurdles In $16B Consumer Pharma Unit Sale To US Private Equity CD&R
Sanofi Might Face Political Hurdles In $16B Consumer Pharma Unit Sale To US Private Equity CD&R
Oct 17, 2024
Last week, Sanofi SA ( SNY )  said it is negotiating with Clayton Dubilier & Rice (CD&R) to potentially sell a 50% controlling stake in Opella, its consumer healthcare business. The deal could be valued at about 15 billion euros ($16.4 billion), making it one of the largest European transactions this year. Sanofi ( SNY ) is likely to retain a minority stake in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved